What are the recommended treatments for migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatments for Migraines

For acute migraine treatment, combination therapy with a triptan (such as sumatriptan) plus an NSAID or acetaminophen is recommended as first-line treatment due to superior efficacy compared to monotherapy. 1, 2

Acute Treatment Algorithm

First-Line Options:

  • NSAIDs:

    • Ibuprofen 400-800mg
    • Naproxen sodium 500mg
    • Aspirin
    • Acetaminophen 1000mg (if NSAIDs contraindicated)
  • Combination therapy (preferred approach):

    • Triptan + NSAID or acetaminophen
    • Aspirin-acetaminophen-caffeine combinations

Second-Line Options (for inadequate response to first-line):

  • Triptans alone:
    • Sumatriptan 25-100mg (50mg often provides optimal balance of efficacy and side effects) 3
    • Other triptans (rizatriptan, zolmitriptan)

Third-Line Options (for inadequate response to triptans):

  • CGRP antagonists (gepants):

    • Rimegepant
    • Ubrogepant
    • Zavegepant
  • Ergot alkaloids:

    • Dihydroergotamine (intranasal or injectable)

Fourth-Line Option:

  • Ditan:
    • Lasmiditan (for patients who don't respond to all other treatments) 1

For Patients with Severe Nausea/Vomiting:

  • Non-oral triptan formulations (nasal spray, injection)
  • Antiemetics (e.g., metoclopramide IV) 2

Important Considerations

Medications to Avoid:

  • Opioids - not recommended for migraine treatment 1, 2
  • Butalbital-containing medications - risk of dependence and medication overuse headache 2

Timing of Treatment:

  • Begin treatment as soon as possible after migraine onset for better efficacy 1
  • Early treatment during mild pain phase provides significantly better outcomes than treating established attacks 4

Medication Overuse Risk:

  • Limit acute treatments to avoid medication overuse headache:
    • Triptans: <10 days/month
    • NSAIDs: <15 days/month 1, 2

Special Populations:

  • Pregnancy/Breastfeeding: Discuss adverse effects of treatments during pregnancy and lactation 1
  • Hepatic Impairment: For sumatriptan, maximum single dose should not exceed 50mg in mild to moderate hepatic impairment 3

Preventive Treatment

Consider preventive treatment if:

  • Frequent episodic migraines
  • Inadequate response to acute treatments 1
  • Risk of progression to chronic migraine 5

Preventive Options:

  1. Beta-blockers:

    • Propranolol (80-240 mg/day)
    • Metoprolol
    • Timolol (20-30 mg/day)
  2. Anti-seizure medications:

    • Topiramate (50-200 mg/day)
    • Divalproex sodium (500-1500 mg/day)
  3. CGRP antagonists:

    • Erenumab
    • Fremanezumab
    • Galcanezumab
  4. Other options:

    • Amitriptyline (30-150 mg/day)
    • Angiotensin II receptor blockers (candesartan, telmisartan)
    • Oral magnesium
  5. For chronic migraine:

    • OnabotulinumtoxinA injections 5

Lifestyle Modifications

  • Regular sleep schedule
  • Regular meal times
  • Moderate to intense aerobic exercise
  • Stress management techniques
  • Maintaining hydration
  • Weight loss if overweight/obese 1, 2

Clinical Pearls

  • Approximately 90% of migraine patients can be effectively managed in primary care 2
  • Sumatriptan 100mg provides better pain-free response than 50mg, but with increased adverse events 3, 4
  • The NNT for sumatriptan 100mg for pain-free at 2 hours is 4.7, while for 50mg it's 6.1 4
  • Consider referral to specialist if treatments fail despite optimization or diagnosis is uncertain 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Migraine Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.